Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05573607 · ClinicalTrials.gov registry record · NA
Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life
A NA study, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05573607 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 26 participants.
The verdict
NCT05573607, a NA study, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is a double-blind, randomized, two-arm, placebo-controlled trial of apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio (i.e. The Center for Applied Health Sciences). Subjects will attend four study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work \[also HgA1c, insulin\], background baseline diet). Over the next 12 weeks, subjects will attend Visits 2-4, wherein assessments of serum glucose, insulin, HOMA-IR, 2-hour glucose tolerance test (GTT), HgA1c, C-reactive protein, adiponectin, ferritin, waist circumference, quality of life questionnaire, and various visual analog scales for appetite, satiety, and cravings will be made.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Chromium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05573607
The ClinicalTrials.gov registry entry for NCT05573607 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05573607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05573607 about?
NCT05573607 is a clinical study titled "Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life". This study is a double-blind, randomized, two-arm, placebo-controlled trial of apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio (i.e. The Center for Applied Health Sciences). Subjects will attend four study visits. During Visit 1, subjects will be...
What is the current status of trial NCT05573607?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-11-19. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT05573607?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Chromium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05573607?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.